Clin2
NCT05435547Possibly a fitRecruiting

Pre-surgery steroid medicine for autoimmune thyroid disease

Graves DiseaseHashimoto Disease

Treatments studied

Part of Eyes & vision, Hormones & metabolism, Immune system & allergy clinical trials.

This trial tests whether taking corticosteroids (anti-inflammatory medicines) before thyroid surgery is safe and helpful for people with autoimmune thyroid disease. It focuses on Graves’ or Hashimoto’s disease patients who are planning total thyroid removal.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
76 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 or older
  • You have Graves’ or Hashimoto’s disease, and blood tests show thyroid autoantibodies
  • You are scheduled for total thyroidectomy (full thyroid removal)
  • You have not had radioactive iodine (RAI) treatment before
  • You have not had prior surgery on your neck
  • You are not on immune-suppressing medicines (and have not recently had steroids or had steroid side effects)
  • You do not have diabetes that requires medication
  • You do not have known thyroid cancer

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07059507Recruiting
Thyroid cancer in Graves' disease patients having thyroid surgery

This study looks at how often thyroid cancer is found by accident in people with Graves' disease who have their thyroid removed. It helps doctors understand who might be at higher risk so they can plan better care.

Minya, Minya Governorate
NCT05461820Recruiting· Phase 4
Testing treatment options for Graves’ disease and its relapse

This study compares different treatment plans to see how well they control Graves’ disease and whether it comes back. It may help by identifying which approach works best to prevent relapse.

Nanjing
NCT07596849Recruiting· Phase 3
Testing a New Injection for Graves' Disease

This study tests efgartigimod, a new medicine given by injection under the skin, to see if it can help control Graves' disease (an overactive thyroid condition). The goal is to reduce the need for other thyroid medications or help people stop taking them.

Surrey
NCT06327828Not yet recruiting
Testing a computer aid for Graves' disease treatment

This study compares computer-guided dosing of methimazole (a common thyroid medication) to standard care for people with active Graves' disease. It tests whether digital support helps manage treatment better.

Graz
NCT06963203Recruiting
Surgery for hyperthyroidism from Graves' or amiodarone use

This study looks at thyroid removal surgery for hyperthyroidism caused by Graves' disease or the heart medication amiodarone. It aims to see how well the surgery works for these patients.

Aalst
NCT05732883Recruiting· Phase 2
Dexamethasone after thyroid surgery to help voice and calcium

This Phase 2 study tests whether giving dexamethasone (a steroid medicine) around the time of total thyroid surgery can improve voice outcomes and reduce low-calcium problems. It may help people avoid hoarseness and symptoms of hypocalcemia after surgery, especially those at risk.

Hong Kong

Hear when a new Graves Disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.